WHO identified Visceral Leishmaniasis (VL) as a Category I disease (emerging and uncontrolled) and the support to the Elimination control programs in India, Nepal and Bangladesh were intensified in 2005. One of the key approaches that allows accelerated efforts towards the elimination process is by focusing on availability, affordability and accessibility of medicines used to treat VL. This presentation by Ms. Aishwarya Kulkarni, who has completed her BPharm, focuses on the evolution of the medicines for VL, their prices and some of the current issues in this regard.

Speaker

Aishwarya

k

Affiliation

IPH Intern

Date

26-July-2018

Time

3.00 pm – 4.00 pm

Venue

Institute of Public Health, Bengaluru
#250, 2nd C Main, 2nd C Cross,
Girinagar Ist  Phase,
Bengaluru – 560085

Admissions open for 2019!

In this eRM (eLearning course in Research Methods) course, we start with helping the student develop clear and well formulated research questions. Participants are then taught how to select research designs and methods best suited to answer the research question, beyond the usual epidemiological disciplines.

You have Successfully Subscribed!